Hepatic encephalopathy therapy: An overview

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 1, Issue 2

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

752

HTML

4000

Tables (1-5)

333

Sum=5085

Apr 6, 2010 (publication date) through Nov 26, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pharmacology and Therapeutics

ISSN

2150-5349

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastrointest Pharmacol Ther. Apr 6, 2010; 1(2): 54-63
Published online Apr 6, 2010. doi: 10.4292/wjgpt.v1.i2.54

Table 5 Possible future approaches to HE treatment

Objectives	Approaches currently used	Proposed approaches under evaluation
To reduce the production of Gut-derived toxins	Disaccharides Low-absorbable antibiotics	Probiotics Fermentable fibers, acarbose Spherical adsorptive carbon (AST 120)
To favor nitrogen metabolism	Liver transplantation Reduction of TIPS diameter Closure of a spontaneous portal systemic shunt Ornithine Aspartate Zinc Sodium benzoate	Artificial liver support Sodium benzoate + phenylacetate (Ammonul) L-ornithine phenylacetate HPN-100 (Phenylbutyrate + phenylacetic acid)
To correct the alterations in neurotransmission	BCAA Flumazenil

Citation: Riggio O, Ridola L, Pasquale C. Hepatic encephalopathy therapy: An overview. World J Gastrointest Pharmacol Ther 2010; 1(2): 54-63
URL: https://www.wjgnet.com/2150-5349/full/v1/i2/54.htm
DOI: https://dx.doi.org/10.4292/wjgpt.v1.i2.54